Tag: SNM

Neuspera announces first successful Nuvella system implant in second phase of...

Neuspera Medical has announced the first patient has been successfully implanted with the Nuvella system in its pivotal SANS-UUI clinical trial, which will evaluate...

Axonics announces first patient implants in Canada with recharge-free sacral neuromodulation...

Axonics has announced the first patient implants in Canada with Axonics F15, the company’s newly developed, long-lived, fully recharge-free sacral neuromodulation (SNM) system. The University...

Axonics receives FDA approval for new recharge-free sacral neuromodulation system

Axonics has announced that the US Food and Drug Administration (FDA) has approved its newly developed, long-lived, recharge-free sacral neuromodulation (SNM) implantable neurostimulator, the...

Medtronic receives FDA approval for InterStim X system for bladder and...

Medtronic has announced receipt of approval from the US Food and Drug Administration (FDA) for its new, recharge-free InterStim system—with the device being made...
Medtronic

Medtronic announces US launch of its InterStim Micro neurostimulator

Medtronic has announced that its recently US Food and Drug Administration (FDA)-approved InterStim Micro neurostimulator for sacral neuromodulation (SNM) therapy is now available in...
Axonics two year results ARTISAN-SNM study

Axonics granted six US patents and allowed three additional patents related...

Axonics has announced that the United States Patent and Trademark Office has issued or allowed Axonics nine US utility patents in 2019, along with...
Axonics two year results ARTISAN-SNM study

Axonics provides survey results from Physician Seminar Series showcasing the recently...

  Axonics, a medical technology company that has developed and is commercialising novel implantable Sacral Neuromodulation (SNM) devices for the treatment of bladder and bowel...
SNM axonics system

Axonics announces first commercial US patient implanted with its sacral neuromodulation...

  Axonics has announced the first US-based implantation of the Axonics r-SNM system subsequent to its clearance by the US Food & Drug Administration (FDA)...
Axonics FDA approval Remote Control

Axonics announces agreement to supply sacral neuromodulation systems to leading urology...

  Axonics has announced that it has entered into an exclusive agreement to supply the Axonics rechargeable sacral neuromodulation (r-SNM) system to Adult Pediatric Urology...